News Focus
News Focus
icon url

Ban Pearl Paw

07/21/20 10:39 AM

#3184 RE: Ban Pearl Paw #3179

HMNU on April 15, 2020 signed a binding preliminary contract with Life Science s.r.l. for the acquisition of the exclusive commercial rights for Usa, Canada and South America of an innovative and efficace natural supplement based of astanxantine for the treatment of respiratory problems and inflammatory problems caused by infections and incontroled virus. www.life-science.it